Please use this identifier to cite or link to this item: https://doi.org/10.1016/j.acthis.2009.05.010
Title: Molecular-assisted immunohistochemical optimization
Authors: Mohd, Omar M.F.
Salto-Tellez, M. 
Huang, N.
Ou, K.
Jikuya, H.
Ichikawa, T.
Tan, P. 
Ou, K.
Yu, K.
Putti, T.C. 
Nishimura, O.
Keywords: Antibody optimization
Immunohistochemistry validation
Molecular biology
Molecular diagnostics
Protein immunolocalization
Issue Date: 2010
Source: Mohd, Omar M.F., Salto-Tellez, M., Huang, N., Ou, K., Jikuya, H., Ichikawa, T., Tan, P., Ou, K., Yu, K., Putti, T.C., Nishimura, O. (2010). Molecular-assisted immunohistochemical optimization. Acta Histochemica 112 (6) : 519-528. ScholarBank@NUS Repository. https://doi.org/10.1016/j.acthis.2009.05.010
Abstract: Immunohistochemistry (IHC) is an essential tool in diagnostic surgical pathology, allowing analysis of protein subcellular localization. The use of IHC by different laboratories has lead to inconsistencies in published literature for several antibodies, due to either interpretative (inter-observer variation) or technical reasons. These disparities have major implications in both clinical and research settings. In this study, we report our experience conducting an IHC optimization of antibodies against five proteins previously identified by proteomic analysis to be breast cancer biomarkers, namely 6PGL (PGLS), CAZ2 (CAPZA2), PA2G4 (EBP1) PSD2 and TKT. Large variations in the immunolocalizations and intensities were observed when manipulating the antigen retrieval method and primary antibody incubation concentration. However, the use of an independent molecular analysis method provided a clear indication in choosing the appropriate biologically and functionally relevant "staining pattern". Without this latter step, each of these contradictory results would have been a priori "technically acceptable" and would have led to different biological and functional interpretations of these proteins and potentially different applications in a routine pathology setting. Thus, we conclude that full validation of immunohistochemical protocols for scientific and clinical use will require the incorporation of biological knowledge of the biomarker and the disease in question. © 2009 Elsevier GmbH. All rights reserved.
Source Title: Acta Histochemica
URI: http://scholarbank.nus.edu.sg/handle/10635/33169
ISSN: 00651281
16180372
DOI: 10.1016/j.acthis.2009.05.010
Appears in Collections:Staff Publications

Show full item record
Files in This Item:
There are no files associated with this item.

SCOPUSTM   
Citations

4
checked on Dec 14, 2017

WEB OF SCIENCETM
Citations

2
checked on Nov 20, 2017

Page view(s)

147
checked on Dec 10, 2017

Google ScholarTM

Check

Altmetric


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.